Avalo Therapeutics (AVTX) Change in Taxes (2017 - 2020)
Avalo Therapeutics (AVTX) reported Change in Taxes of $839000.0 for Q2 2020, up 298.73% on a YoY basis from $210416.9 in Q3 2019, and up 252.27% quarter-over-quarter from -$551000.0 in Q1 2020.
Avalo Therapeutics (AVTX) Change in Taxes (2017 - 2020) Analysis & Trends
Avalo Therapeutics has reported Change in Taxes for 4 years, with the latest figure at $839000.0 in Q2 2020.
- For the quarter ending Q2 2020, Change in Taxes rose 298.73% year-over-year to $839000.0; the trailing twelve-month figure through Mar 2021 stood at $839000.0 (up 146.25% YoY), and the FY2020 full-year result was $288000.0, up 119.45% from the prior year.
- Change in Taxes for Q2 2020 stood at $839000.0, up from -$551000.0 in the prior quarter.
- The five-year high for Change in Taxes was $3.2 million in Q3 2017, with the low at -$970852.0 in Q4 2017.
- Historically, Change in Taxes has averaged $69972.6 across 4 years, with a median of -$190199.0 in 2018.
- Annual changes were most pronounced in 2019 — Change in Taxes slumped 3040.65% — and 2020, when it soared 298.73%.
- Avalo Therapeutics' Change in Taxes stood at -$970852.0 in 2017, then jumped by 83.23% to -$162790.0 in 2018, then sank by 184.28% to -$462783.0 in 2019, then soared by 281.29% to $839000.0 in 2020.
- The last three Change in Taxes figures came in at $839000.0 (Q2 2020), -$551000.0 (Q1 2020), and -$462783.0 (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Avalo Therapeutics | 295.77 Mn | 295.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 839,000.00 |
| Jun 30, 2020 | 839,000.00 |
| Mar 31, 2020 | -551,000.00 |
| Mar 31, 2020 | -551,000.00 |
| Dec 31, 2019 | -462,783.00 |
| Dec 31, 2019 | -462,783.00 |
| Sep 30, 2019 | -378,020.00 |
| Sep 30, 2019 | -378,020.00 |
| Jun 30, 2019 | -422,176.00 |
| Jun 30, 2019 | -422,176.00 |
| Mar 31, 2019 | -217,608.00 |
| Mar 31, 2019 | -217,608.00 |
| Dec 31, 2018 | -162,790.00 |
| Dec 31, 2018 | -162,790.00 |
| Sep 30, 2018 | 24,000.00 |
| Sep 30, 2018 | 24,000.00 |
| Jun 30, 2018 | -95,500.00 |
| Jun 30, 2018 | -95,500.00 |
| Mar 31, 2018 | 7,400.00 |
| Mar 31, 2018 | 7,400.00 |